People talk about their glow as if it’s magic, but the truth is even better: Inside that tiny abdomen is a chemical reaction ...
Chronic obstructive pulmonary disease (COPD) is an inflammatory disorder that causes several symptoms which make breathing difficult. These include persistent cough with mucus, wheezing, and shortness ...
There are moments in life with chronic obstructive pulmonary disease (COPD) that divide everything into the before and the after. Some are dramatic, such as the first hospitalization or the first time ...
When the word pleurodesis first entered my life, it was not abstract, but was tethered to the reality of three pneumothoraces since 2010. Each lung collapse was a reminder of how suddenly breath could ...
Share this page with email Share this page on Facebook Share this page on X Share this page on Reddit Print Preferred Source on Google The experimental therapy tozorakimab from AstraZeneca was ...
What types of exercise benefit patients with chronic obstructive pulmonary disease (COPD)? In my opinion, the quick answer is “all of them,” but let’s take a closer look. According to Harvard Health, ...
DirectRx, a specialty pharmacy for people with chronic health disorders, is now part of the exclusive U.S. pharmacy network distributing Ohtuvayre (ensifentrine), a newly approved therapy for chronic ...
It’s not uncommon for those of us with chronic obstructive pulmonary disease (COPD) to suffer from cachexia, or wasting disease. A 2019 study found that people with cachexia or pre-cachexia had a ...
Share this page with email Share this page on Facebook Share this page on X Share this page on Reddit Print Preferred Source on Google Using e-cigarettes, often called vaping, significantly increases ...
Share this page with email Share this page on Facebook Share this page on X Share this page on Reddit Print Preferred Source on Google Many of us fall into a quiet trap as we get older. A new ache ...
Yupelri (revefenacin) is not superior to Spiriva (tiotropium) at improving lung function in adults with severe chronic obstructive pulmonary disease (COPD), according to data from a Phase 4 clinical ...
The U.S. Food and Drug Administration (FDA) has approved ReAlta Life Sciences’ request to launch a Phase 2 clinical trial testing its experimental anti-inflammatory therapy RLS-0071 in people with ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results